Last updated: 3 months ago
Aptevo Therapeutics Inc. Q4 2024 Financial Report: Losses Surge Amid Liquidity Concerns
Explore Aptevo Therapeutics Inc.'s Q4 2024 financial report highlighting a net loss of $24.13M, declining cash reserves, and strategic partnerships amid operational challenges.